Featured Research

from universities, journals, and other organizations

Mice Regain Ability To Extend Telomeres Suggesting Potential For Dyskeratosis Congenita Therapy

Date:
October 19, 2009
Source:
The Company of Biologists
Summary:
A new study reveals that mice used as a model for the human genetic disease dyskeratosis congenita, have short telomeres for 10 generations when they are interbred. In later generations, the mice regain the ability to lengthen telomeres. Discovering how to induce this equilibration process in DKC patients could suggest new treatment strategies to decrease the genomic instability in their high turnover tissues.

Mice and DKC patients share a genetic deficiency that shortens their telomeres, the caps that protect the ends of each chromosome; studying how the mice recover normal telomere length could lead to novel treatments for this genetic disorder.

The human genetic disease dyskeratosis congenita (DKC) is an autosomal dominant disease that leads to abnormalities in tissues with a rapid cell turnover – the skin, nails, bone marrow, lungs and gut. Patients with DKC experience life-threatening symptoms. Bone marrow failure increases their risk of fatal infections and cancer. Many die before the age of 30 and management of the disease is limited to trying to treat its symptoms.

At the heart of DKC is telomerase, the enzyme that maintains the length of telomeres, the protective caps on the ends of chromosomes. Telomerase has two main components; telomerase reverse transcriptase (TERT) and telomerase RNA. The latter is the template that TERT uses to produce telomere-extending DNA. Patients with DKC have a mutation in one TERT allele and under produce telomerase. This leads to a failure to maintain normal telomere length. Once the chromosomes erode beyond a certain point, they start to rearrange and cells show increasing genomic instability followed by cell death and tissue malfunction.

"DKC is one of the few examples in which there is a clear link between a genetic mutation that directly affects telomerase function and human disease," comments senior author Lea Harrington (Ontario Cancer Institute, Toronto, ON, Canada). "Teasing out the difference between cause and effect is a challenge."

mTert mice, which have one functional TERT allele and one disrupted allele, also show telomere shortening and represent a useful model for DKC. Research with this mouse model now aims to determine the potential for adaptive extension of telomeres. The underlying mechanisms could suggest novel therapies for DKC and could lead to methods of blocking telomerase inhibition in normal tissues during cancer therapy, so improving treatment efficacy.

"mTert mice provide an appropriate model for DKC that we can use to examine the long term consequences of TERT deficiency over several generations in a controlled setting," explains Harrington.

In this study, researchers interbred mice with only one functional TERT allele for up to 14 generations to observe telomere length and integrity. Initial generations of the inbred mtert mice had telomeres that were significantly shorter than those of normal mice but they did not develop DKC-like symptoms because the short telomere caps were sufficient to prevent chromosomal instability. In later generations, the telomeres in the mTert mice regained normal lengths, showing that an equilibration process eventually occurs after 12-14 generations.

"This was initially a puzzling finding; we examined and re-examined this phenomenon intensively over three years, using different experimental designs to be sure that the results were reproducible," says Harrison.

The authors speculate that the equilibration mechanism they observed might already occur in humans and may protect normal human stem cells from telomere erosion. They also suggest that activation of a similar equilibration process in the cells of DKC-affected patients could reduce disease symptoms. It could be a useful adjuvant to cancer therapy in DKC and cancer patients generally.


Story Source:

The above story is based on materials provided by The Company of Biologists. Note: Materials may be edited for content and length.


Journal Reference:

  1. Marie Meznikova, Natalie Erdman, Lea A Harrington and Rich Allsopp. Telomerase reverse transcriptase-dependent telomere equilibration mitigates tissue dysfunction in mTert heterozygotes. Disease Models & Mechanisms, Volume 2 Issue 11/12

Cite This Page:

The Company of Biologists. "Mice Regain Ability To Extend Telomeres Suggesting Potential For Dyskeratosis Congenita Therapy." ScienceDaily. ScienceDaily, 19 October 2009. <www.sciencedaily.com/releases/2009/10/091019122848.htm>.
The Company of Biologists. (2009, October 19). Mice Regain Ability To Extend Telomeres Suggesting Potential For Dyskeratosis Congenita Therapy. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2009/10/091019122848.htm
The Company of Biologists. "Mice Regain Ability To Extend Telomeres Suggesting Potential For Dyskeratosis Congenita Therapy." ScienceDaily. www.sciencedaily.com/releases/2009/10/091019122848.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins